Treatment with high dose aflibercept 8 mg can lead to similar visual outcomes with fewer injections for patients with RVO.
The hybrid injectables HA-CaHA and HA-CaHA-L are effective and safe for up to 1 year for the treatment of midface volume deficit.
One Good Thing by Jillee on MSN
40 Exceedingly Useful Hydrogen Peroxide Hacks
To make a de-skunking solution, combine one quart of hydrogen peroxide, 1/4 cup of baking soda, one teaspoon of dish soap, ...
Medpage Today on MSN
Investigational Combination Shows Promise in Chronic Hepatitis D
WASHINGTON -- An investigational dual therapy appeared to show antiviral activity in patients with chronic hepatitis D virus (HDV) infection, according to the phase II SOLSTICE trial.
Both tobevibart (a monoclonal antibody) and elebsiran (a small interfering RNA) target hepatitis B virus surface antigen (HBsAg). Their efficacy and safety in the treatment of chronic hepatitis D ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback